VIEW
IN BROWSER
EDITOR'S
NOTE: Big4Bio newsletters will not be
published from Dec 16, 2025, to Jan 4, 2026; they
will resume distribution on Monday, Jan 5, 2026.
|
Co-Producer
|
|
| december
15, 2025 |
| Covering
Life Sciences Drugs, Diagnostics,
Devices, Digital Health |
|
|
|
* may need subscription to view |
|
|
| Mark
your calendars for March 11, 2026
– join us for the Annual Dinner
& Showcase to celebrate the PA
life sciences community and award
honorees at the Philadelphia Art
Museum. |
|
Learn More
→ |
|
|
- Incyte: Change to Its Board of Directors More
- Johnson & Johnson: U.S. FDA Approves
AKEEGA as the First Precision Therapy for
BRCA2-Mutated Metastatic
Castration-Sensitive Prostate Cancer With
54% Reduction in Disease Progression vs
Standard of Care* More
- Medicus Pharma: Completes Enrolment of
Ninety (90) Patients for Phase 2 Clinical
Study (SKNJCT-003) to Non-Invasively Treat
Basal Cell Carcinoma (BCC) of the Skin More
- Mineralys Therapeutics: Phase 3 Launch-HTN
Trial of Lorundrostat Recognized in Inaugural
Journal of the American Medical Association
(JAMA) "Research of the Year" Roundup More
- Palvella Therapeutics: Positive Topline
Results From Phase 2 TOIVA Clinical Trial of
QTORIN 3.9% Rapamycin Anhydrous Gel (QTORIN
rapamycin) for the Treatment of Cutaneous
Venous Malformations, a Serious, Rare Genetic
Disease With No FDA-approved Therapies More
- Pilatus Biosciences: FDA Clearance of IND
Application for PLT012, a First-in-Class
Anti-CD36 Metabolic Checkpoint Antibody in
Solid Tumors More
|
|
 |
|
Investment Banking Advisory to the
Life Science Industry |
|
Learn More
→ |
|
|
- Cencora: Accelerates OneOncology
Acquisition, Extending Solutions Offering
for Community Oncology More
- Impulse Dynamics Clinches $158M for
Chronic Heart Failure Implant More
More
More
More
- JPM
Week Conference Readiness Packages (Big4Bio
Subscriber Discount) More
- Save
on Exclusive Biotech Intelligence & VC
Funding Data from BYTE51 More
- TELA Bio: Inducement Grants Under Nasdaq
Listing Rule 5635(c)(4) More
|
|
 |
Pace®
Life Sciences
The CDMO That Takes You Further.
Your partner for Product
Development, Manufacturing,
Analytical Testing, Regulatory
Consulting & Operational
Support. |
|
Learn More
→ |
|
|
- Subscribe to LifeSci Startup for
Updates on US Startups More
- The Big4Bio Podcast: Every Moment
Matters: Integrating AI into Drug Discovery
Podcast
|
|
|
DISCOVER COMPANIES |
|
Big4Bio: Philadelphia Life Science
Company Directory |
|
Locate a specific company or
explore new companies in life
science. |
|
Explore
our Company Directory
|
Provided courtesy
of
 |
|
|
|
Feature your company |
| Apply
to have your company
showcased by Big4Bio |
|
|
|
|
|
 |
|
Premier Executive Search and
Talent Advisory Firm Slone
Partners Launches Fractional
Talent Service to Deliver
On-Demand Leaders and Specialists
|
|
Learn More
→ |
|
|
- M&A in Life Sciences: The Turning
Tide – Why Now is a Strategic Inflection for
Biopharma and Biotech More
- ICYMI: CEO’s Perspective: Big Moves Come
with Big Responsibility More
- ICYMI: CEO’s Perspective: The High Cost of
Job Hopping More
- ICYMI: Elevating Executive Presence: A
Blueprint for Life Sciences and Biotech
Leaders More
- ICYMI: The Power of Peer Learning - Why Even
Top Biotech Leaders Need Mentorship More
- ICYMI: What’s Next in Precision Medicine:
Leadership Challenges and Opportunities More
- SJU: Path to Commercialization in Healthcare
- Angelo Maletta-Hastie
(Founder/President/COO/CIO of Pulmonara Labs)
More
- The Rise of Fractional Talent in Life
Sciences: What to Expect in 2026 More
|
|
 |
|
|
|
You are
receiving this email because
you signed up for one of our
newsletters at Big4Bio.com,
signed up at one of our
partner or sponsor events,
or given as a gift
subscription by your firm or
organization. Unsubscribe
Big4Bio:Philadelphia,
all rights reserved 2025
© 2025
Big4Bio, a division of
BigBio Communications. All
rights reserved.
|
|
|
|
|
